Metabolic Syndrome and Risk of Cardiovascular Disease: A Meta-Analysis

This publication has 31 references indexed in Scilit:

• C-Reactive Protein, the Metabolic Syndrome, and Prediction of Cardiovascular Events in the Framingham Offspring Study
  Circulation, 2004
• Prevalence of the Metabolic Syndrome and Its Relation to All-Cause and Cardiovascular Mortality in Nondiabetic European Men and Women
  Archives of internal medicine (1960), 2004
• The metabolic syndrome and mortality from cardiovascular disease and all-causes: findings from the National Health and Nutrition Examination Survey II Mortality Study
  Atherosclerosis, 2004
• Clinical Importance of Obesity Versus the Metabolic Syndrome in Cardiovascular Risk in Women
  Circulation, 2004
• Which Features of the Metabolic Syndrome Predict the Prevalence and Clinical Outcomes of Angiographic Coronary Artery Disease?
  Cardiology, 2004
• The Metabolic Syndrome is an independent predictor of cardiovascular disease in Type 2 diabetic subjects. Prospective data from the Verona Diabetes Complications Study
  Diabetic Medicine, 2003
• Metabolic Syndrome With and Without C-Reactive Protein as a Predictor of Coronary Heart Disease and Diabetes in the West of Scotland Coronary Prevention Study
  Circulation, 2003
• Metabolic syndrome: major impact on coronary risk in a population with low cholesterol levels—a prospective and cross-sectional evaluation
  Atherosclerosis, 2002
• Comment on the provisional report from the WHO consultation
  Diabetic Medicine, 1999
• Meta-analysis in clinical trials
  Controlled Clinical Trials, 1986